Chengda Pharmaceuticals
Jiashan, Zhejiang, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Chengda Pharmaceuticals
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Jiashan, Zhejiang, China
- Website
- https://www.chengdapharm.com/CDMO/list.aspx?lcid=82
- Modalities
- Small Molecule API, Intermediates
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Chengda Pharmaceuticals
Chengda Pharmaceuticals makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates. 1 manufacturing site registered with the U.S. FDA. Website: https://www.chengdapharm.com/CDMO/list.aspx?lcid=82
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Chengda Pharmaceuticals FDA Inspection History
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-11-15 |
Chengda Pharmaceuticals Co., Ltd.
Jiashan, JiaXing
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Chengda Pharmaceuticals
How many FDA inspections does Chengda Pharmaceuticals have on record?
CDMO Signal tracks 1 FDA inspection for Chengda Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has Chengda Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Chengda Pharmaceuticals.
Does Chengda Pharmaceuticals have a CDMO Signal Score?
Not yet. Chengda Pharmaceuticals is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Chengda Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare Chengda Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Changzhou Qihui Pharmaceutical
Changzhou, Jiangsu, China
Small Molecule API, Veterinary, Intermediates
Jiangxi Fushine Pharmaceutical
Jingdezhen, Jiangxi, China
Small Molecule API, Intermediates, Custom Synthesis
Jiangxi Synergy Pharmaceutical
Fengxin, Jiangxi, China
Small Molecule API, Intermediates
Shanghai Desano
Shanghai, China
Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide
Agno Pharma
Lianyungang, Jiangsu, China
Small Molecule API, Intermediates, Sterile Injectables, Clinical Trial Manufacturing
Compare Chengda Pharmaceuticals with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.